Pharmaceutical Executive January 13, 2022
Pharmaceutical Executive Editorial Staff

Nick Cernese is a Health Sciences and Wellness partner at EY. He has spent the last 20 years as a management consultant, leading interdisciplinary teams across the globe and working with large and complex pharmaceutical, medical device, and health technology companies worldwide as they navigate through disruption, innovation and transformation.

He and his team are passionately focused on helping these organizations determine their role in creating platforms that effectively share trusted health-related information. In this way, they are helping individuals make empowered choices about their care.

Pharm Exec: What are the challenges that life sciences companies face today when it comes to putting content out in a timely manner?

Nick Cernese: With the digital technology explosion, there are so many more...

Today's Sponsors

H1
ZeOmega
Holon

Today's Sponsors

SalesSparx
Canton & Company

Today's Sponsor

Premier

 
Topics: Biotechnology, Interview / Q&A, Pharma / Biotech, Trends
In Developing Nations, mRNA Boosters Can Be Great Investment
The time is right: Another shot to end cancer as we know it
Payers Need to Make Effort for Improvements in Biosimilars
Expert: Cell, Gene Therapy Research Has Weathered the Storm of COVID-19, Leaving a Bright Future Ahead
Prioritizing physician wellness: Reducing burnout during the COVID-19 pandemic and beyond [PODCAST]